Oncology Specialty Residency

Hematology and Oncology Specialty Residency

WFBH offers an ASHP-accreditated, one-year, specialty residency in oncology at a NCI designated Comprehensive Cancer Center.  The residency is designed to provide the resident with a broad range of hematology and oncology experiences in a progressive environment committed to pharmaceutical care and education.  These experiences combine learning opportunities in a multidisciplinary setting for both inpatients and outpatients.  One position is available each year.

Fundamentals

Clinical experiences

Clinical experiences are available in each of the following patient populations:

  •  Blood & Marrow Transplant (BMT) - required
  •  Leukemia - required 
  •  Medical Oncology - required 
  •  Pediatric Oncology 
  •  Gynecology Oncology 
  •  Ambulatory Hematology and Oncology Clinic - longitudinal 
  •  Pain Management 
  •  Palliative Care 
  •  Nutrition Support 
  •  Infectious Diseases 

Preceptors

  • LeAnne Kennedy, PharmD, BCOP, CPP
  • Jennifer Ziegler, PharmD, BCOP 
  • Heather Cox, PharmD, BCOP
  • Brandy Snyder, PharmD, BCOP 
  • Erica Wands, PharmD
  • Kara Loth, PharmD, BCOP
  • Mona Benrashid, PharmD, BCOP
  • Danielle Waldron, PharmD, BCOP
  • Joe Bonkowski, PharmD, MS, MHA (practice management)

Rotations

Members of the pharmacy staff participate in daily patient care rounds, therapeutic drug monitoring, medication reconciliation, patient education, providing drug information, and in-service education.

Flexibility allows the resident to tailor experiences to meet their individual interests and career goals.

  •  One month rotations which could be made into blocks of multiple months 
  •  In July, the resident will spend time learning order verification and distribution system for chemotherapy  patients 
  •  December will be left open as a research and administration month 
  •  Remaining 10 rotations are broken into 7 required rotations and 3 elective rotations 
  •  All rotations precepted by qualified clinical specialists 

Clinical experiences 

Required Rotations

  • Blood and Marrow Transplant (BMT)
  • Leukemia
  • Medical Oncology, inpatient
  • Introduction to Outpatient Oncology, clinic
  • Breast, clinic
  • Medical Oncology, clinic (GU/GI/Thoracic)
  • Pediatric Oncolcogy
  • Practice Management - longitudinal
  • Practice Experience (clinic and inpatient) - longitudinal

Electives

  • Gynecology Oncology
  • Leukemia, outpatient
  • Lymphoma, outpatient
  • Hematology, outpatient
  • Head/neck, outpatient
  • Sarcoma/melanoma, outpatient
  • BMT, oupatient
  • Pediatric Oncology, outpatient
  • Pallative Care
  • Nutrition Support
  • Infectious Disease
  • Investigational Drug Services

Presentations

Written and verbal communication skills are emphasized throughout the program.  Presentation opportunities include:

  • Pharmacotherapy CE Program 
  • Journal Club 
  • Case Presentations 
  • Didactic Lecture at Campbell University School of Pharmacy and Health Sciences 
  • Staff Development presentations 
  • Inservices on rotations 
  • Project Presentation at the Southeastern Residency Conference 
  • Presentation at a national meeting such as ASHP Midyear, HOPA 
  • Lay Public Education

Precepting

By precepting students, the oncology resident will have the opportunity to refine their teaching skills and further deepen their own clinical knowledge base.

  • WFBMC is a rotation site primarily for students from Campbell University and Wingate Colleges of Pharmacy (approximately 160 student months per year) 
  • Precepting responsibilities available on many rotations 
  • For those residents who have not received a teaching certificate, they may complete the teaching certificate
    program at WFBH.

ProjectsSpecial resident oncology

The oncology resident will complete:

  •  A minimum of one independent research project 
  •  A manuscript for publication 
  •  Mentoring provided by pharmacy preceptors 

Benefits

  •  Comprehensive benefit package 
  •  Estimated stipend: $45,000 
  •  Paid holiday and vacation time 
  •  Funding to attend professional meetings (HOPA and ASHP Midyear) 
  •  Office with computer 
  •  Covered parking 

 

 Former Residents (Current Positions)

 

2005-2006

Mandy Confer Gatesman, PharmD, BCOP

Virginia Commonwealth University,
Clinical Coordinator, Oncology
Residency Director PGY2
2006-2007
Jennifer Davis, PharmD, BCOP
MD Anderson Cancer Center,
Clinical Specialist-Sarcoma
2007-2008 Heather D Cox, PharmD, BCOPWFBH-Oncology Clinical Pharmacist
2008-2009

Violette Sun Basorun (Ajiboye), PharmD
MBA, BCOP
Georgia Health Sciences Medical
Center-Clinical Coordinator,
Oncology Residency Director PGY2
2009-2010M Jay Brown, PharmD, BCOPForsyth Medical Center, Clinical Coordinator
2010-2011Kara Loth, PharmD, BCOPWFBH-Oncology Clinical Pharmacist
2011-2012Danielle Waldron, PharmD, BCOPWFBH-Oncology Clinical Pharmacist
2012-2013Meghan Devine, PharmD     

Levine Children's Hospital Carolinas Medical Center, Pediatric Oncology Pharmacist

2013-2014Morgan Pendleton, PharmDCurrent PGY2 resident, WFBMC

 

 


Application Process Oncology Specialty Residency

Applications will be accepted through http://www.ashp.org/phorcas .

 

      Questions about the application process can be directed to Dr. Kennedy at :
lakenned@wakehealth.edu  

An index of our residency programs are located below:
Pharmacy Practice Residency (PGY1)
Advanced Pratice Specialty (PGY2)
     Critical Care 
     Infectious Disease
     Oncology
      Pediatrics
Health System Pharmacy Administration (Masters)

Quick Reference

Oncology Residency
LeAnne Kennedy, PharmD
Clinical Coordinator

336-713-3416

Contact email:
lakenned@wakehealth.edu

Find A Doctor Ways to Give
Last Updated: 02-13-2014
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.